ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Current Assets
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Other Current Assets of -$1.84 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2023-02-08
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2022 was -$1.84M.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2021 was -$8.18M, a 194.41% decline from fiscal 2020.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2020 was $8.67M.
| Period end | Increase (Decrease) in Other Current Assets 12 month |
|---|---|
| 2022-12-31 | -$1.84M 10-K · filed 2023-02-08 |
| 2021-12-31 | -$8.18M 10-K · filed 2023-02-08 |
| 2020-12-31 | $8.67M 10-K · filed 2023-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |